Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Olfactory dysfonction in multiple sclerosis: role for subventricular zone progenitors].
Risk Factors Associated with the Onset of Relapsing-Remitting and Primary Progressive Multiple Sclerosis: A Systematic Review.
CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical Subtypes.
Post trauma vision syndrome and visual midline shift syndrome.
[von Willebrand factor and adhesion molecules in patients with multiple sclerosis.]
Involvement of ER Stress in Dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 Missense Mutations Shown by iPSC-Derived Oligodendrocytes.
Remission with fingolimod in a case of demyelinating polyneuropathy.
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters.
Cannabinoids decrease the th17 inflammatory autoimmune phenotype.
Improving the clinical correlation of multiple sclerosis black hole volume change by paired-scan analysis.
Early onset multiple sclerosis: a review for nurse practitioners.
Adenosine A1 receptor agonist, N6-cyclohexyladenosine, protects myelin and induces remyelination in an experimental model of rat optic chiasm demyelination; electrophysiological and histopathological studies.
Helicobacter pylori Infection in Neuromyelitis Optica and Multiple Sclerosis.
Increased Th17 response to myelin peptides in pediatric MS.
Autologous Haematopoietic Stem Cell Transplantation with Reduced Intensity Conditioning in Multiple Sclerosis.
[Will multiple sclerosis (MS) susceptibility genes one day become biomarkers for MS diagnosis?]
Benfotiamine upregulates antioxidative system in activated BV-2 microglia cells.
Multiple sclerosis: managing a complex neurological disease.
Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case-control study.
Novel serum autoantibodies against talin1 in multiple sclerosis: Possible pathogenetic roles of the antibodies.
Comparing two conditions of administering the six-minute walk test in people with multiple sclerosis.
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging.
The role of mast cells in neuroinflammation.
1,25-Dihydroxyvitamin D3 Suppresses TLR8 Expression and TLR8-Mediated Inflammatory Responses in Monocytes In Vitro and Experimental Autoimmune Encephalomyelitis In Vivo.
Autophagy and autoimmunity crosstalks.
Pages
« first
‹ previous
…
281
282
283
284
285
286
287
288
289
…
next ›
last »